SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044624
Filing Date
2021-08-16
Accepted
2021-08-16 16:07:38
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-10q_20210630.htm   iXBRL 10-Q 2905018
2 EX-4.1 annx-ex41_417.htm EX-4.1 39805
3 EX-10.1 annx-ex101_791.htm EX-10.1 267777
4 EX-31.1 annx-ex311_6.htm EX-31.1 20304
5 EX-31.2 annx-ex312_8.htm EX-31.2 20236
6 EX-32.1 annx-ex321_7.htm EX-32.1 15181
  Complete submission text file 0001564590-21-044624.txt   8284811

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA annx-20210630.xsd EX-101.SCH 40300
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE annx-20210630_cal.xml EX-101.CAL 51996
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE annx-20210630_def.xml EX-101.DEF 113343
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20210630_lab.xml EX-101.LAB 354094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20210630_pre.xml EX-101.PRE 259295
12 EXTRACTED XBRL INSTANCE DOCUMENT annx-10q_20210630_htm.xml XML 1257362
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 211178096
SIC: 2834 Pharmaceutical Preparations